Assistance Publique - Hôpitaux de Paris: Atrial Fibrillation trials

The registry lists 21 Atrial Fibrillation studies with Assistance Publique - Hôpitaux de Paris as lead sponsor. 8 are open to participants now and 0 have results posted.

Phase 2 2Phase 3 3Phase 4 2No phase 15(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• The Effect of Pulse Field Ablation of Atrial Fibrillation Involving Posterior Wall Ablation on Atrial Mechancis Assessed by Cardiac Magnetic Resonance ImagingNot yet recruitingNCT07499531Not applicable
• Magnetic Resonance Imaging Development for High Resolution Atrial Structural and Functional CharacterizationNot yet recruitingNCT06617624
• The Effect of Pulse Field Ablation on Atrial Mechanics in Catheter Ablation of Paroxysmal Atrial FibrillationRecruitingNCT06557876Not applicable
• Stroke Prevention In Ischemic Stroke With Covert Atrial FibrillationRecruitingNCT06486792Phase 4
• Left Atrial Appendage Closure Registry of Henri Mondor HospitalRecruitingNCT05565209
• Combined Study of ATrial Strain and Voltage by High Density Mapping in Young Patients With Atrial Fibrillation.Not yet recruitingNCT05565183Not applicable
• Rate, Rhythm or Risk Control for New-onset Supraventricular Arrhythmia During Septic Shock: a Randomized Controlled TrialRecruitingNCT04844801Not applicable
• Contribution of Computed Tomography and Cardiac-MRI in Atrial Fibrillation AblationRecruitingNCT04281329
• Computed Tomography of Pulse-Field AblationCompletedNCT07395089
• Connected Cardiology to Control Cardiac RythmWithdrawnNCT06091514Not applicable
• Study of Interference Between Oral Anticoagulants and Heparin During Ablation of Atrial Fibrillation (AF) or Left Atrial Tachycardia (GAD) by Catheter.CompletedNCT05802576
• Assessment of Flecainide to Lower the Patent Foramen Ovale Closure Risk of Atrial Arrhythmia or TachycardiaActive, not recruitingNCT05213104Phase 3
• Multidisciplinary Team Approach to Prescribe Antithrombotic Therapy in Older People With Atrial FibrillationCompletedNCT04932603
• Prevention Atrial Fibrillation by BOTulinum Toxin Injections (BOTAF)Active, not recruitingNCT04075981Phase 3
• Assessment of Dual Antiplatelet Therapy Versus Rivaroxaban In Atrial Fibrillation Patients Treated With Left Atrial Appendage ClosureCompletedNCT03273322Phase 2/3
• Sleep Apnea and Atrial Fibrillation RecurrenceCompletedNCT02906839Not applicable
• Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 75 Years and Over Suffering From Non Valvular Atrial Fibrillation (nv AF)Status unknownNCT02906527
• Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 80 Years and OverCompletedNCT02286414
• Medical Economical Evaluation of the Ablation by Catheter of the Atrial Tissue in the Treatment of AFCompletedNCT01183091
• Pharmacodynamic Drug Interaction Between Warfarin and Amoxicillin-clavulanic AcidCompletedNCT00603317Phase 4
• Arrhythmia Prevention With an Alpha-Linolenic Enriched DietCompletedNCT00410020Phase 2